• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Shengjie, WANG Li, TIAN Zhimei. Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method[J]. Journal of China Pharmaceutical University, 2019, 50(5): 572-578. DOI: 10.11665/j.issn.1000-5048.20190510
Citation: ZHANG Shengjie, WANG Li, TIAN Zhimei. Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method[J]. Journal of China Pharmaceutical University, 2019, 50(5): 572-578. DOI: 10.11665/j.issn.1000-5048.20190510
shu

Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method

More Information
    Graphical Abstract
    • Abstract
  • An HPLC-DAD wavelength switching method(240 nm, 280 nm, 316 nm, 403 nm)was developed for simultaneous determination of seven index components: hydroxysafflor yellow A, paeoniflorin, ferulic acid, salvianolic acid B, kaempferol, formononetin and tanshinone IIA in Naoxintong capsule. The qualities of different batches of Naoxintong capsules were evaluated by statistical analysis. Seven index components in 20 batches of Naoxintong capsules were simultaneously determined by HPLC wavelength switching method with Capcell PAK C18 MG II column(250 mm × 4. 6 mm, 5. 0 μm). The mobile phase consisted of methanol-acetonitrile(25 ∶75, A)-0. 1% formic acid aqueous solution(B)with a gradient elution program and a flow rate of 1. 0 mL/min, and the column temperature was 30 °C. The results were analyzed by statistical analysis to evaluate the differences in the quality of Naoxintong capsules. Results showed that the seven active components were well separated and showed good linearity hydroxysafflor yellow A(403 nm)2. 30- 11. 50 mg/L(r=0. 999 2), paeoniflorin(240 nm)8. 81- 44. 05 mg/L(r=0. 999 6), ferulic acid(316 nm)1. 22- 6. 10 mg/L(r=0. 999 6), salvianolic acid B(280 nm)11. 61- 58. 05 mg/L(r=0. 999 4), kaempferol(403 nm)1. 16-5. 80 mg/L(r=0. 999 4), formononetin(240 nm)0. 12- 0. 60 mg/L(r=0. 999 5)and tanshinone IIA(280 nm)2. 28- 11. 40 mg/L(r=0. 999 5). The precision was good and RSD was less than 2. 0%, The repeatability was good and RSD was less than 2. 0%. The stability was good in 24 h. The average recoveries were between 97. 35%- 101. 02% and RSD was less than 2. 0%. The contents of target components in Naoxintong capsules, hydroxysafflor yellow A was 0. 213- 0. 369 mg/g, paeoniflorin was 1. 535- 3. 217 mg/g, ferulic acid was 0. 153- 0. 236 mg/g, salvianolic acid B was 2. 563- 3. 271 mg/g, kaempferol was 0. 103- 0. 181 mg/g, formononetin was 0. 022- 0. 028 mg/g, and tanshinone IIA was 0. 466- 0. 698 mg/g. HPLC wavelength change and gradient elution method was established for simultaneous determination of seven index components in Naoxintong capsule. The method is accurate, sensitive, reliable, and repeatable, and can be used for the quality control of Naoxintong capsule.
    • FullText(HTML)
    • References (23)
  • [1]
    Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:1301-1302.
    [2]
    Wang SS,Xu HY,Ma Y,et al.Characterization and rapid identification of chemical constituents of Naoxintong capsules by UHPLC-linear ion trap/Orbitrap mass spectrometry[J].J Pharm Biomed Anal,2015,111:104-118.
    [3]
    Sun Z,Zhou L,Li ZL,et al.The chemical constituents study of Naoxintong capsules based on UHPLC-Q-Orbitrap HRMS[J].China J Chin Mater Med(中国中药杂志),2018,53(19):1687-1695.
    [4]
    Li RR.Clinical analysis of Naoxintong capsule in the treatment of acute ischemic cerebral apoplexy[J].J Front Med(医药前沿),2018,8(33):150-151.
    [5]
    Li WX,Zhang SQ,Zhao YD,et al.Study progress on chemical compounds pharmacological action and clinical application of Naoxintong capsule[J].China J Chin Mater Med(中国中药杂志),2018,43(10):1998-2005.
    [6]
    Liu YR,Tang ZS,Song ZX,et al.Q-markers in Naoxintong capsules by using multivariable statistical and “components-targets-diseases” network analysis[J].Chin Tradit Herb Drugs(中草药),2018,49(12):2775-2785.
    [7]
    Su R,Tang ZS,Liu F,et al.HPLC-DAD fingerprint of Naoxintong capsules[J].Cent South Pharm(中南药学),2019,17(1):1-4.
    [8]
    Su H,He JB,Hou PH,et al.Study on HPLC fingerprint and comtent determination of Naoxintong capsules[J].Hebei Med J(河北医药),2015,37(5):764-767.
    [9]
    Li J,Bai Y,Bai Y,et al.Pharmacokinetics of caffeic acid,ferulic acid,formononetin,cryptotanshinone,and tanshinone IIA after oral administration of Naoxintong capsule in rat by HPLC-MS/MS[J].Evid Based Complement Alternat Med,2017,2017:1-12.
    [10]
    Xu HY,Shi Y,Zhang YQ,et al.Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach[J].Mol Biosyst,2016,12(1):233-245.
    [11]
    Zhang HL,Cui YX,Wang SM,et al.Determination of paeoniflorin in Naoxintong capsules by HPLC[J].J Chin Med(中医学报),2010,25(1):118-119.
    [12]
    Chen JS,Wang ZY,Chen AH,et al.Determination of protocatechu aldehyde in Naoxintong capsule by HPLC[J].Guide J Tradit Chin Med Pharm(中医药导报),2015,21(22):34-36.
    [13]
    Zhang LQ,Zhang XM,Wang R,et al.Determination of paeoniflorin in Naoxintong tablet by HPLC[J].Anhui Med Pharm J(安徽医药),2011,15(8):958-959.
    [14]
    Wang YB.Determination of danshensu in Naoxintong capsules by HPLC[J].Pract J Cardiac Cereb Pneum Vasc Dis(实用心脑肺血管病杂志),2008(5):29-30.
    [15]
    Wang CJ,Sun BG,Zhang J,et al.Determination of the content of paeoniflorin in Naoxintong capsules by HPLC[J].J Pharm Res(药学研究),2006(3):153-155.
    [16]
    Li G,Meng FX,Yang,et al.UPLC simultaneous determination of five components in Naoxintong capsules[J].Chin J Pharm Anal(药物分析杂志),2013(3):414-418.
    [17]
    Wei QY,Xu YJ.Determination of paeoniflorin,ferulic acid,salvianolic acid b and tanshinone ⅡA in Naoxintong capsule by microemulsion electrokinetic chromatography[J].J Anal Sci(分析科学学报),2013,29(2):159-163.
    [18]
    Li TT,Hai HY,Zhang B,et al.Analysis of hydroxysafflor yellow A and kaempferol in Carthamus tinctorrius L.by Xinjiang and Henan[J].J Liaoning Univ Tradit Chin Med(辽宁中医药大学学报),2017,19(9):67-70.
    [19]
    Ding LL,Duan CP,Li F,et al.The determination of hydroxysafflor yellow A and kaempferol in Carthamus tinctorrius L.by different collecting time and parts[J].J Shenyang Pharm Univ(沈阳药科大学学报),2015,32(1):65-69.
    [20]
    Chen FX,Gao R,Zhang BK,et al.Advances in cardiovascular effects of tanshinone ⅡA[J].China J Chin Mater Med(中国中药杂志),2015,40(9):1649-1653.
    [21]
    Wang JT,Peng DY,Liu JQ,et al.Comparison the contents of tanshinone IIA in Salvia miltiorrhiza of different origin[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2008,14(3):4-5.
    [22]
    Hu D,Wang GZ.Comparison of tanshinone IIA contents in different parts of Salvia miltiorrhiza[J].Chin Med Mat(中药材),2005,28(1):34-35.
    [23]
    Zhao XJ,Wang SJ,Wu AL,et al.Study on degradation law of tanshinone ⅡA by heating in Radix Salvia Miltiorrhizae[J].Chin Pharm(中国药业),2009,18(14):23-24.
    • Related Articles

  • Related Articles

    [1]HUO Zirui, PEI Jieyu, ZHAN Fangyi, XIE Shaowen, XU Jinyi, XU Shengtao. Research advances in small-molecule hydrophobic tagging protein degraders[J]. Journal of China Pharmaceutical University, 2025, 56(2): 252-263. DOI: 10.11665/j.issn.1000-5048.2024031301
    [2]YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
    [3]CAO Jin, CHEN Hao, ZHANG Jing, ZHU Jianwei, CHEN Junsheng. Expression and purification of soluble recombinant antibody fragment and immunotoxin in Escherichia coli using Npu DnaE C-cleavage mutant[J]. Journal of China Pharmaceutical University, 2020, 51(2): 213-222. DOI: 10.11665/j.issn.1000-5048.20200213
    [4]TAO Linlin, HUO Meirong, XU Wei. Advances in the research of protein nanocarrier materials[J]. Journal of China Pharmaceutical University, 2020, 51(2): 121-129. DOI: 10.11665/j.issn.1000-5048.20200201
    [5]LI Qingmei, WANG Shuzhen. Advances of relationship between protein Neddylation and cancer[J]. Journal of China Pharmaceutical University, 2018, 49(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20180303
    [6]ZHANG Xinran, LI Bo, DI Bin. Advances in racemization of protein amino acid[J]. Journal of China Pharmaceutical University, 2017, 48(4): 407-415. DOI: 10.11665/j.issn.1000-5048.20170404
    [7]Wu Mengqiu, WU Mengqiu, LU Gaoyuan, SHAO Chang, WANG Dandan, SUN Di, HAO Haiping, WANG Guangji. Mass spectrometry-based protein quantification and its application in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2015, 46(2): 129-140. DOI: 10.11665/j.issn.1000-5048.20150201
    [8]Progress in Protein Microarray and Its Applications[J]. Journal of China Pharmaceutical University, 2001, (5): 11-14.
    [9]IMPROVEMENT OF PROTEIN DETERMINATION WITH COOMASSIE BRILLIANT BLUE G-250 DYE[J]. Journal of China Pharmaceutical University, 1987, (2): 133-136.
    [10]Chen Qionghua. The Nutrition Value of Fermented Soy Bean Curd Protein[J]. Journal of China Pharmaceutical University, 1979, (2): 7-12.

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365818

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return